Pitarys C J, Virmani R, Vildibill H D, Jackson E K, Forman M B
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.
Circulation. 1991 Jan;83(1):237-47. doi: 10.1161/01.cir.83.1.237.
Adenosine influences the function of several cell types thought to be involved in the pathogenesis of myocardial reperfusion injury. We have previously demonstrated that intracoronary administration of adenosine enhances myocardial salvage 24 hours after reperfusion. To determine if these beneficial effects could be obtained during a prolonged period of reperfusion using an intravenous route of administration, 22 closed-chest dogs were subjected to 90 minutes of proximal left anterior descending coronary artery occlusion and 72 hours of reperfusion. Animals randomly received either intravenous adenosine (0.15 mg/kg/min) or an equal volume of Ringer's lactate during the first 150 minutes of reperfusion. The area at risk was defined in vivo with Monastral blue, and infarct size was measured histologically with Mallory's trichrome stain. Serial global and regional ventricular function were determined with contrast ventriculography and analyzed using a computerized radial shortening method. Biopsies were obtained from the central ischemic zone to assess endothelial ultrastructure and capillary obstruction. No significant effects in heart rate or blood pressure were noted during adenosine infusion. Transmural collateral blood flow during ischemia was similar in the groups. Infarct size expressed as a percentage of the anatomical area at risk was significantly less in the adenosine-treated group (35.3 +/- 4.3% in controls versus 17.1 +/- 4.3% in treated animals, p less than 0.01). A progressive decrease in transmural blood flow was noted in control animals during reperfusion, resulting in a significant reduction at 3 hours compared with the preocclusion value (0.69 +/- 0.11 ml/min/g [at baseline versus 0.45 +/- 0.10 ml/min/g at 3 hours, p less than 0.05]). In contrast, flow in adenosine animals at 3 hours was similar to baseline values (0.91 +/- 0.15 ml/min/g at baseline versus 0.98 +/- 0.14 ml/min/g at 3 hours, p = NS) and was significantly higher (p less than 0.05) than the control group. Radial shortening in the ischemic zone was significantly improved at 3 (-2.6 +/- 2.8% in controls versus 11.6 +/- 3.3% in treated animals, p less than 0.01) and 72 hours (5.5 +/- 2.0% in controls versus 17.3 +/- 3.5% in treated animals, p less than 0.01) after reperfusion in treated animals. Electron microscopy showed reduced neutrophil and erythrocyte plugging of capillaries with relative preservation of endothelial cell structure in the adenosine group.(ABSTRACT TRUNCATED AT 400 WORDS)
腺苷会影响几种被认为参与心肌再灌注损伤发病机制的细胞类型的功能。我们之前已经证明,冠状动脉内给予腺苷可在再灌注24小时后增强心肌挽救。为了确定使用静脉给药途径在延长的再灌注期间是否能获得这些有益效果,对22只闭胸犬进行了90分钟的左前降支冠状动脉近端闭塞和72小时的再灌注。在再灌注的前150分钟内,动物随机接受静脉腺苷(0.15mg/kg/分钟)或等体积的乳酸林格液。用莫那斯特蓝在体内确定危险区域,并用马洛里三色染色组织学测量梗死面积。用对比心室造影确定系列全心和局部心室功能,并使用计算机化径向缩短方法进行分析。从中心缺血区获取活检组织以评估内皮超微结构和毛细血管阻塞情况。在输注腺苷期间未观察到对心率或血压有显著影响。两组在缺血期间的透壁侧支血流相似。以危险解剖区域的百分比表示的梗死面积在腺苷治疗组中显著更小(对照组为35.3±4.3%,治疗动物组为17.1±4.3%,p<0.01)。在再灌注期间,对照组动物的透壁血流逐渐减少,与闭塞前值相比,在3小时时显著降低(基线时为0.69±0.11ml/分钟/克,3小时时为0.45±0.10ml/分钟/克,p<0.05)。相比之下,腺苷组动物在3小时时的血流与基线值相似(基线时为0.91±0.15ml/分钟/克,3小时时为0.98±0.14ml/分钟/克,p=无显著性差异),且显著高于对照组(p<0.05)。在治疗动物中,再灌注后3小时(对照组为-2.6±2.8%,治疗动物组为11.6±3.3%,p<0.01)和72小时(对照组为5.5±2.0%,治疗动物组为17.3±3.5%,p<0.01)时,缺血区的径向缩短显著改善。电子显微镜显示,腺苷组毛细血管中的中性粒细胞和红细胞阻塞减少内皮细胞结构相对保留。(摘要截短至400字)